DealsArchiMed acquires majority stake in NAMSANAMSA is ArchiMed's third investment from its 1 billion euros MED Platform I fund.ByChris Witkowsky1 September 2020•3 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs